Kristine M.
Kristine M. Karnos, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20150186743 | IMAGE PROCESSING UTILIZING REFERENCE IMAGES - Embodiments are generally related to image processing utilizing reference images. An embodiment of a mobile device includes an image capture mechanism to capture a base image, the base image containing one or more objects including a target object; and a memory to store data, the data including the base image. The mobile device is to analyze the base image to identify one or more objects in the base image, and identify one or more reference images based on a comparison of one or more identified objects in the base image with reference images in a repository of images, wherein the one or more reference images include a first reference image containing the target object, the first reference image having a first set of first image characteristics. | 07-02-2015 |
Kristine M. Kim, Chuncheon KR
Patent application number | Description | Published |
---|---|---|
20140162890 | METHODS FOR PREPARING MONOCLONAL ANTIBODIES RECOGNIZING GLYCAN BINDING SITE AS AN EPITOPE - The present disclosure relates to a method for producing a monoclonal antibody that binds to an epitope for the glycan binding site of a glycoprotein. According to the present disclosure, a monoclonal antibody that recognizes the glycan binding site of a glycoprotein as an epitope can be produced in a relatively simple and economic manner, and a monoclonal antibody having high sensitivity and specificity for the glycan binding site of a glycoprotein can be produced. The monoclonal antibody produced according to the present disclosure can be effectively used as an agent for diagnosing or treating various diseases associated with a change in glycan structure or glycan expression level. | 06-12-2014 |
Kristine M. Larsen-Kelly, Lino Lakes, MN US
Patent application number | Description | Published |
---|---|---|
20100049279 | ADAPTIVE SOFTWARE CONFIGURATION FOR A MEDICAL DEVICE - This document describes, among other things, a method of operating a medical device comprising updating a regulatory approval status stored in at least one of the medical device or a second device operable to communicate with the medical device, and enabling or disabling the at least one function in the medical device based on the regulatory approval status. The regulatory approval status corresponds to at least one function performable by the medical device. | 02-25-2010 |
Kristine M. Relvini, Oviedo, FL US
Patent application number | Description | Published |
---|---|---|
20080243928 | Human Factors Process Failure Modes and Effects Analysis (HF PFMEA) Software Tool - Methods, computer-readable media, and systems for automatically performing Human Factors Process Failure Modes and Effects Analysis for a process are provided. At least one task involved in a process is identified, where the task includes at least one human activity. The human activity is described using at least one verb. A human error potentially resulting from the human activity is automatically identified, the human error is related to the verb used in describing the task. A likelihood of occurrence, detection, and correction of the human error is identified. The severity of the effect of the human error is identified. The likelihood of occurrence, and the severity of the risk of potential harm is identified. The risk of potential harm is compared with a risk threshold to identify the appropriateness of corrective measures. | 10-02-2008 |
Kristine M. Swiderek, Woodinvlle, WA US
Patent application number | Description | Published |
---|---|---|
20090280562 | MATERIALS AND METHODS FOR PREPARING DIMERIC GROWTH FACTORS - Proteins consisting of, from amino to carboxyl terminus, a first PDGF-D growth factor domain polypeptide, a linker polypeptide, and a second PDGF-D growth factor domain polypeptide, and materials and methods for making the proteins are disclosed. Each of the first and second PDGF-D growth factor domain polypeptides consists of a sequence of amino acid residues as shown in SEQ ID NO:2 or SEQ ID NO:4 from amino acid x to amino acid y, wherein x is an integer from 246 to 258, inclusive, and y is an integer from 365-370, inclusive. The linker polypeptide consists of from 11-40 amino acid residues. The proteins can be used to stimulate the production of bone and/or connective tissue in both humans and non-human animals. | 11-12-2009 |